The standard-of-care in breast cancer (BC) with positive sentinel lymph node (SLN) metastasis includes complete axillary lymph node dissection (ALND); however, almost half of such cases have no further tumor burden. This study aimed to assess the clinicopathological factors that predict non-SLN metastasis to define subgroups of SLN-positive patients in whom the axilla may be staged by SLN biopsy alone, while avoiding unnecessary overtreatment.
Orsaria, P., Caredda, E., Genova, F., Materazzo, M., Capuano, I., Vanni, G., et al. (2018). Additional nodal disease prediction in breast cancer with sentinel lymph node metastasis based on clinicopathological features. ANTICANCER RESEARCH, 38(4), 2109-2117 [10.21873/anticanres.12451].
Additional nodal disease prediction in breast cancer with sentinel lymph node metastasis based on clinicopathological features
Orsaria P.;Vanni G.;Granai A. V.;de Majo A.;Sileri P.;Petrella G.;Palombi L.;Buonomo O. C.
2018-04-01
Abstract
The standard-of-care in breast cancer (BC) with positive sentinel lymph node (SLN) metastasis includes complete axillary lymph node dissection (ALND); however, almost half of such cases have no further tumor burden. This study aimed to assess the clinicopathological factors that predict non-SLN metastasis to define subgroups of SLN-positive patients in whom the axilla may be staged by SLN biopsy alone, while avoiding unnecessary overtreatment.| File | Dimensione | Formato | |
|---|---|---|---|
|
1de31a59664108111620ea4b6a14f4cc.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
200.74 kB
Formato
Adobe PDF
|
200.74 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
